低强度聚焦超声通过胆碱能抗炎通路改善缺血性心力衰竭
本研究在大鼠心肌梗死模型中探讨低强度聚焦超声(LIFU)对缺血性心力衰竭的作用及神经免疫机制。结果显示LIFU降低心率并改善心脏结构与功能,该效应依赖迷走神经完整性,且伴随炎症因子下降和胆碱能抗炎通路介质表达上调。LIFU有望成为心血管疾病的新型无创非药物治疗手段。
要点
- LIFU可改善缺血性心力衰竭大鼠的心脏结构与功能,效应依赖迷走神经完整性。
- LIFU降低心率,迷走神经切断后该效应消失。
- LIFU抗炎作用与胆碱能抗炎通路介质表达上调相关。
核心结论
- LIFU改善缺血性心力衰竭,胆碱能抗炎通路在其中发挥重要作用。
- LIFU有潜力成为冠心病及其他心血管疾病的新型非药物无创治疗。
研究设计与样本
- 研究为动物实验,使用Sprague-Dawley大鼠。
- 通过左前降支结扎诱导心肌梗死,梗死后每日3次LIFU治疗共25天。
- 采用超声特定参数干预,记录心电图分析心率,迷走神经切断用于机制验证。
- 采用超声心动图、Masson染色和ELISA评估心脏结构与功能。
- 采用ELISA、流式细胞术、qRT-PCR和Western blot分析炎症及胆碱能抗炎通路介质。
关键影像表现/征象
- LIFU降低大鼠心率(control vs LIFU,P < .01),迷走神经切断消除该效应(VT vs LIFU + VT,P > .01)。
- LIFU改善心肌梗死后的心脏结构与功能(MI vs MI + LIFU,P < .01),迷走神经切断后该获益消失(MI + VT vs MI + LIFU + VT,P > .01)。
- LIFU治疗后炎症因子水平下降、抗炎巨噬细胞比例增加、胆碱能抗炎通路相关介质表达增加(MI vs MI + LIFU,P < .01)。
临床应用与阅片要点
- 本研究为动物实验,LIFU参数和结果尚不能直接用于临床阅片或报告。
- 影像评估采用超声心动图观察心脏结构与功能,可作为临床前研究参考。
- 迷走神经完整性是LIFU发挥心脏保护效应的必要条件,提示患者选择需考虑神经调节状态。
局限性
- 研究为动物实验,结果外推到人类需进一步临床验证。
- 原文未报告样本量、随机化及盲法细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aims to determine the effect of low-intensity focused ultrasound (LIFU) in ischemic heart failure (IHF) and explore the potential neuroimmune mechanism.
METHODS: Sprague-Dawley rats were subjected to ultrasound (US) with specific parameters, and electrocardiograms were recorded to analyze the effect of LIFU and/or vagal denervation on heart rate. Thereafter, myocardial infarction (MI) was induced by left anterior artery ligation, and LIFU was performed three times a day for 25 days after MI. Echocardiography, Masson staining, and ELISA were used to evaluate the effect of LIFU on the structure and function of the heart. Finally, ELISA, flow cytometry, qRT-PCR, and Western blot analysis were performed to determine the effect of LIFU on the inflammation and the expression of the cholinergic anti-inflammatory pathway (CAP)-related mediators.
RESULTS: LIFU reduced heart rate in rats (control vs LIFU, P < .01), and vagotomy (VT) eliminated this effect of LIFU on heart rate (VT vs LIFU + VT, P > .01). LIFU-ameliorated IHF in terms of cardiac structure and function (MI vs MI + LIFU, P < .01), but VT abrogated the beneficial effect of LIFU (MI + VT vs MI + LIFU + VT, P > .01). After the treatment of LIFU, decreased levels of inflammatory cytokines, increased proportion of anti-inflammatory macrophages, and increased expression of CAP-related mediators (MI vs MI + LIFU, P < .01).
CONCLUSIONS: LIFU ameliorates IHF whereas the CAP plays a promising role. LIFU has the potential to be a novel nonpharmacological and noninvasive therapy for the treatment of coronary artery disease and other cardiovascular diseases.
引用
- Zhong, Cai, Zhong, et al. Low-Intensity Focused Ultrasound Ameliorates Ischemic Heart Failure Related to the Cholinergic Anti-Inflammatory Pathway. J Ultrasound Med. 2022. PMID: 36444908. doi:10.1002/jum.16140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。